According to our (Global Info Research) latest study, the global Diagnostic Radiopharmaceuticals market size was valued at US$ 5556 million in 2024 and is forecast to a readjusted size of USD 8727 million by 2031 with a CAGR of 6.7% during review period. Radiopharmaceuticals refer to a special class ...

Summary According to APO Research, The global Nuclear Medicine & Radiopharmaceuticals market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031. North American market for Nuclear Medicine ...

Summary According to APO Research, the global Nuclear Medicine & Radiopharmaceuticals market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031. North American market for Nuclear Medicine & Radiopharmaceuti ...

Summary According to APO Research, The global Nuclear Medicine & Radiopharmaceuticals market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for Nuclear Medicine & Radiopharmaceutica ...

Summary According to APO Research, The global Radiopharmaceuticals in Nuclear Medicine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for Radiopharmaceuticals in Nuclear Medi ...

Summary According to APO Research, The global Radiopharmaceuticals in Nuclear Medicine market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031. North American market for Radiopharmaceut ...

Summary According to APO Research, the global Radiopharmaceuticals in Nuclear Medicine market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031. North American market for Radiopharmaceuticals in Nuclear Me ...

Summary According to APO Research, the global Radiopharmaceuticals in Nuclear Medicine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period. The North American market for Radiopharmaceuticals in Nuclear M ...

This study covers the world outlook for radiopharmaceuticals and contrast media across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the ...

This study covers the world outlook for SPECT radioisotope radiopharmaceuticals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the ...

This study covers the world outlook for radiopharmaceutical and therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the co ...

This study covers the world outlook for radiopharmaceuticals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the ...

This study covers the world outlook for radiopharmaceuticals-nuclear medicines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the ...

This study covers the world outlook for nuclear medicine-radiopharmaceuticals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the c ...

This study covers the world outlook for imaging agents across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region ...

This study covers the world outlook for diagnostic radiopharmaceuticals and contrast media across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percen ...

This study covers the world outlook for diagnostic radiopharmaceuticals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country ...

This study covers the world outlook for diagnostic radiopharmaceutical imaging agents across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent sha ...

This study covers the world outlook for medical cyclotrons across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the re ...

The Africa anticancer drugs market is expected to reach US$ 3.23 billion by 2031 from US$ 1.81 billion in 2024. The market is estimated to grow with a CAGR of 8.8% from 2025 to 2031. The Africa anticancer drugs market forecast presented in this report can help stakeholders in this marketplace plan t ...

Global Diagnostic Radiopharmaceuticals and Contrast Media Market to Reach US$13.6 Billion by 2030 The global market for Diagnostic Radiopharmaceuticals and Contrast Media estimated at US$10.9 Billion in the year 2024, is expected to reach US$13.6 Billion by 2030, growing at a CAGR of 3.7% over the a ...

Global Imaging Agents Market to Reach US$13.4 Billion by 2030 The global market for Imaging Agents estimated at US$10.3 Billion in the year 2024, is expected to reach US$13.4 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Diagnostic Radiopharmaceuticals, one of the se ...

Global Radiopharmaceuticals Market to Reach US$14.3 Billion by 2030 The global market for Radiopharmaceuticals estimated at US$7.6 Billion in the year 2024, is expected to reach US$14.3 Billion by 2030, growing at a CAGR of 11.0% over the analysis period 2024-2030. Oncology, one of the segments anal ...

Report Scope This report analyzes the global market for radiopharmaceuticals, in terms of quantitative and qualitative data, to help readers understand the market, to assess business/growth strategies, and to make informed business decisions regarding radiopharmaceuticals. BCC Research estimates mar ...

Radiopharmaceuticals Market Trends and Outlook Radiopharmaceuticals are specialized drugs containing radioactive isotopes for diagnosing and treating various medical conditions, especially cancer, cardiovascular diseases, and neurological disorders. In diagnostics, radiopharmaceuticals act as tracer ...